INMB
Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Inmune Bio, Inc. (INMB)Equibles does not estimate personal net worth.
Get an email with a short summary when Inmune Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get INMB alertsDan Carson is recorded as Head of Investor Relations at Inmune Bio, Inc. (INMB). Dan Carson has spoken on 1 earnings call across 1 company, most recently for Inmune Bio, Inc. on November 5, 2026. Inmune Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inmune Bio, Inc. includes David J. Moss (CEO and Board Member), J. Kelly Ganjei (Chairman), Cory Ellspermann (Board Member) and 7 others.
“We thank you for joining us for the call for ImmuneBio's third quarter 2026 financial results. Presenting on today's call are David Moss, CEO and co-founder of ImmuneBio, Dr. Mark Lodell, Chief Scientific Officer and co-founder of ImmuneBio, and Corey Elsperman, ImmuneBio CFO.”
INMB
Biotechnology · Healthcare
Head of Investor Relations